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Park, Ki-Sook, Nam-Gu Lee, Ki-Hoo Lee, Jeong Taeg
Seo, and Kang-Yell Choi. The ERK pathway involves pos-
itive and negative regulations of HT-29 colorectal cancer cell
growth by extracellular zinc. Am J Physiol Gastrointest Liver
Physiol 285: G1181–G1188, 2003. First published June 19,
2003; 10.1152/ajpgi.00047.2003.—Dietary zinc is an impor-
tant trace element in the body and is related to both cell
proliferation and growth arrest. A recent study found that
extracellular zinc-sensing receptors trigger intracellular sig-
nal transduction in HT-29 human colorectal cancer cells.
However, the signaling mechanism causing this growth reg-
ulation by extracellular zinc is not clearly understood. At 10-
and 100-M levels of ZnCl2 treatment, HT-29 cell growth and
proliferation increased and decreased, respectively, in a min-
imally serum-starved medium (MSSM). A lack of significant
increase in intracellular zinc levels after zinc treatment sug-
gested that this differential growth regulation of HT-29 cells
by extracellular zinc is acquired by receptor-mediated signal
transduction. Moreover, this zinc-induced growth regulation
was differentially affected by PD-98059, suggesting the in-
volvement of the ERK pathway. Transient ERK activation
and subsequent cyclin D1 induction were observed on adding
10 M ZnCl2 in MSSM in the presence of cell proliferation.
On the other hand, prolonged ERK activity was observed
with a subsequent increase of cyclin D1 and p21Cip/WAF1 on
adding 100 M ZnCl2 in MSSM, and this was associated with
nonproliferation. Moreover, this ERK activation and cyclin
D1 and p21Cip/WAF1 induction were abolished by PD-98059
pretreatment. The differential regulations of cell growth,
ERK activities, and cyclin D1 and p21Cip/WAF1 inductions
were also observed in serum-enriched medium containing
higher zinc concentrations. Therefore, differential cell cycle
regulator induction occurs by a common ERK pathway in the
differential growth regulation of HT-29 cells by extracellular
zinc.
signal transduction; extracellular signal-regulated kinase;
p21Cip/WAF1
ZINC IS INVOLVED IN THE STIMULATION of cell growth, and a
zinc deficiency inhibits growth in animals, causes pro-
liferation in cultured cells, and accelerates established
tumor growth (23, 38). However, it has also been re-
ported that zinc has an antitumor effect that is asso-
ciated with growth inhibition (2, 9, 19, 39). The levels
of zinc in tumorous and normal tissues differ (8, 21,
37), and cell growth may be affected by zinc dosage (8,
29). The epithelium of the colonic epithelial mucosa
undergoes continuous renewal, and the growth and
tumorigenesis of colorectal cells are highly sensitive to
zinc levels (5, 24, 25). However, the mechanism of the
differential growth regulation of cells by zinc remains
unknown.
Extracellular zinc is reported to activate signaling
pathways related to cell growth regulation, such as
MAPK and phosphoinositol 3-kinase pathways (17, 20,
28, 32), and the chelation of intracellular zinc does not
change the activation status of MAPK by extracellular
zinc (14). Moreover, cellular growth regulation by zinc
is not likely to be mediated by direct interaction with
intracellular metalloproteins, because symptoms of
zinc deficiency precede changes in the intracellular
zinc content (6, 20). Recently, Hershfinkel et al. (15)
reported the presence of an extracellular zinc-sensing
receptor (ZnR) in HT-29 colorectal cancer cells and
suggested its involvement in extracellular receptor-
mediated signaling pathway(s) for growth regulation.
In the present study, we investigated the mechanism
of the differential regulation of HT-29 colorectal cancer
cell growth at nontoxic micromolar concentrations of
extracellular zinc. HT-29 colorectal cancer cell growth
was found to be positively and negatively regulated by
different extracellular zinc concentrations, which re-
sulted from differential ERK activation. Moreover, cy-
clin D1 and p21Cip/WAF1 cell cycle regulators were also
differentially induced, and this was also found to depend
on ERK activation and to be related to the differential
regulation of cell growth. No significant accumulation of
intracellular zinc by the application of micromolar con-
centrations of extracellular zinc suggests that the effects
of zinc are mediated by receptor-mediated signal trans-
duction rather than being due to complex effects associ-
ated with intracellular zinc accumulation (18, 34).
METHODS
Cell culture. HT-29 cells were maintained in McCoy’s 5A
medium supplemented with 10% FBS, 100 U/ml penicillin,
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and 250 ng/ml streptomycin in 5% CO2 at 37°C. Unless
otherwise stated, the experiments were performed on cells at
70% confluence. To observe the effects of zinc, the cells were
grown in McCoy’s 5A containing either 1 or 10% FBS for
16–20 h before zinc treatment. In required cases, 1, 5, or 10
M of the MEK inhibitor PD-98059 (Calbiochem, La Jolla,
CA) was given 30 min before ZnCl2 addition.
Cell counting and thymidine incorporation. HT-29 colorec-
tal cells were grown in minimally serum-starved medium
(MSSM) containing 1% FBS for 16 h. The cell culture me-
dium was replaced with fresh 1 or 10% FBS medium contain-
ing different concentrations of ZnCl2 (0–500 M). The at-
tached cell numbers were counted by mounting 10 l of the
cell mixture (1:1 mixture of 0.4% trypan blue and HT-29 cell
suspension) onto a Tiefe Depth Profondeur 0.0025-mm2 cell-
counting plate (Superior) and observing plated cells under a
microscope.
For thymidine incorporation, the HT-29 cells were plated
in 12-well culture dishes at 1.3  105 cells/well and then
grown in MSSM for 16–20 h. The medium was then replaced
with fresh MSSM containing different ZnCl2 concentrations
(0, 10, or 100 M), and the cells were further incubated for
40 h. When required, PD-98059 was also added 30 min before
ZnCl2 treatment. Finally, the incubations were continued in
the presence of [3H]thymidine (0.5 Ci/well) for 8 h. After
cells were washed twice with 5% trichloroacetic acid, they
were solubilized by the addition of 0.2 N NaOH, and DNA-
associated 3H activity was counted by using a liquid scintil-
lation counter.
Western blot analysis. Cell extracts were prepared from
harvested cells as previously described (28). Samples of 10–
50 g protein from the whole cell extracts were separated by
SDS-PAGE, and the blots were prepared on a Protran mem-
brane. The following antibodies were used as probes: for
ERK, phosphospecific anti-ERK (New England Biolabs, Bev-
erly, MA) and anti-ERK (Stratagene, La Jolla, CA) antibod-
ies; for cyclin D1 and p21Cip/WAF1, anti-cyclin D1 and -p21Cip/
WAF1 antibodies (Santa Cruz Biotechnology, Santa Cruz,
CA). The blots were probed with horseradish peroxidase-
conjugated secondary antibodies (Transduction Laboratories,
San Diego, CA), and the proteins were visualized by en-
hanced chemiluminescence.
Measurement of intracellular zinc. The intracellular zinc
concentration ([Zn2]i) in HT-29 cells was measured by using
a modification of a method described previously (34). HT-29
cells were plated onto coverslips at a density of 3  105
cells/coverslip into six-well plates, and the cells were grown
overnight in McCoy’s 5A medium containing 1 or 10% FBS
and treated with ZnCl2 at 1, 100, or 500 M. Cells were then
loaded with the fluorescent indicator mag-fura-2 at 37°C in a
5% CO2 incubator by including 3 M of the acetoxymethyl
ester of mag-fura-2 (mag-fura-2 AM; Molecular Probes, Eu-
gene, OR) for 20 min in a HCO3
-buffered solution containing
(in mM): 110 NaCl, 4.5 KCl, 1 NaH2PO4, 1 MgSO4, 1.5 CaCl2,
5 HEPES-Na, 5 HEPES-free acid, 25 NaHCO3, and 10 D-
glucose (pH 7.4). Cells were then rinsed twice and incubated
in the HCO3
-buffered solution for at least 20 min before use.
[Zn2]i was measured on the stage of an inverted micro-
scope (Nikon, Tokyo, Japan) by spectrofluorometry (Photon
Technology International, New Brunswick, NJ) while cells
were superfused at a constant perfusion rate of 2 ml/min with
HCO3
-buffered solution equilibrated with 95% O2-5% CO2 to
maintain a pH of 7.4. All experiments were performed at
37°C. The excitation wavelength alternated between 340 and
380 nm, and emission fluorescence was recorded at 510 nm.
The values of [Zn2]i were calculated by using a modification
of the equation described by Grynkiewicz et al. (12): [Zn2]i
Kd  Sf2/Sb2[(R  Rmin)/(Rmax  R)], in which Kd of mag-
fura-2 for Zn2 was assumed to be 20 nM (36), R is the
observed 340/380 fluorescence ratio, Rmin is the 340/380
fluorescence ratio value determined in mag-fura-2-loaded
HT-29 cells exposed to 100 M TPEN, Rmax is the 340/380
fluorescence ratio value [obtained by adding 20 M 1-hy-
droxypyridine-2-thione (pyrithione; Sigma, St. Louis, MO), a
Zn2 ionophore, in the presence of 1 mM Zn2], Sf2 is the
fluorescence intensity at 380 nm at Rmin, and Sb2 is the
fluorescence intensity at 380 nm at Rmax.
Statistical analysis. The statistical significances of differ-
ences between the positive- and negative-regulated groups
were determined by using a one-way ANOVA and Bonferro-
ni’s test. A P value 0.05 was considered statistically signif-
icant. The results are expressed as means  SD.
RESULTS
HT-29 cell growth and proliferation were positively
or negatively regulated by 5–100 M of ZnCl2 in
MSSM. The number of cells was measured after the
extracellular zinc treatments to determine the role of
zinc in regulating the growth of HT-29 cells. The num-
bers of HT-29 cells increased up to 72 h after a ZnCl2
treatment at 10 M in MSSM containing 1% FBS
(Fig. 1A). On the other hand, the number of cells
decreased after increasing the ZnCl2 concentration to
80–100 M (Fig. 1A). Unlike the cells grown in MSSM,
the number of cells increased as a result of the treat-
ments in the range of 5–100 M ZnCl2 in a medium
containing 10% FBS (Fig. 1B). The lack of growth
inhibition by 100 M ZnCl2 in the medium containing
10% FBS suggests that ZnCl2 at this concentration is
not toxic to HT-29 cells. Because 10 and 100 M ZnCl2
resulted in the most significant effects in terms of the
positive and negative regulation of HT-29 cell growth
in MSSM, we used these two zinc concentrations in
further studies involving MSSM.
The level of DNA synthesis was measured by deter-
mining the extent of [3H]thymidine incorporation and
was found to increase in cells by more than twofold on
adding 10 M ZnCl2 to MSSM (Fig. 1C). The amount of
thymidine incorporated by 10 M ZnCl2 was only
slightly lower than that level acquired by growing cells
in medium containing 10% FBS without zinc treatment
(Fig. 1C). However, the thymidine incorporation level
was reduced by adding 100 M ZnCl2 to cells grown in
MSSM.
Positive and negative regulation of zinc-treated
HT-29 cell growth by PD-98059 in MSSM. The ERK
pathway is involved in cell cycle arrest (7, 35, 40) and
is well known to be a function of cell cycle progression
(4, 7). The ERKs were previously found to be strongly
activated in a prolonged manner by 100 M ZnCl2
treatments in MSSM, and this activation was related
to the antiproliferation of colorectal cancer cells, in-
cluding HT-29 cells (28). However, ERK activities were
also found to be transiently and weakly activated by
extracellular zinc treatment (14, 33). This growth reg-
ulation was not further investigated with respect to
differential ERK regulation. In this study, we investi-
gated the growth and proliferation induced by the
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different zinc concentrations and their relationship
with the ERK activation profiles.
Cell numbers, which had been previously increased
by 10 M ZnCl2 in MSSM, were dose-dependently
decreased by treatment with the MEK inhibitor PD-
98059 (Fig. 2A), suggesting that ERK activation affects
the proliferation of HT-29 cells by 10 M ZnCl2 in
MSSM. Surprisingly, cell numbers reduced by 100 M
ZnCl2 treatment in MSSM were increased by subse-
quently treating the cells with 1 M PD-98059 (Fig.
2B). These results suggest that the ERK activation by
100 M ZnCl2 in MSSM, which caused growth inhibi-
tion (28), was blocked by 1 M PD-98059. A further
increase in PD-98059 to 5 and 10 M in the cells
treated with 100 M ZnCl2 resulted in a further reduc-
tion in the number of cells (Fig. 2B). These results
suggest that the ERK pathway may be involved in both
the positive and negative regulation of cell growth and
further suggest that the zinc-induced growth regula-
tion of HT-29 cells may be highly sensitive to the level
of ERK activation. The upregulation of cell numbers by
PD-98059 in 100 M ZnCl2-treated cells in MSSM
confirms that 100 M ZnCl2 is not a toxic concentration
to HT-29 cells. The thymidine incorporation level,
which was increased by adding 10 M ZnCl2, was also
dose-dependently inhibited by pretreating the cells
with PD-98059 in MSSM (Fig. 2C). However, the thy-
midine incorporation level was also increased by the 1
M PD-98059 cotreatment in the cells treated with 100
M ZnCl2 and was reduced by cotreatment with 10 M
PD-98059 (Fig. 2C) compared with 1 M PD-98059
cotreatment. Therefore, cell numbers in this system
were found to be highly correlated with proliferation
status. The differential modulations of cell growth and
proliferation by PD-98059 suggest that the ERK path-
way participates in both the proliferation and the an-
tiproliferation of cellular growth.
The cyclin D1 and p21Cip/WAF1 are differentially in-
duced by 10 and 100 M ZnCl2 in MSSM and are
dependent on ERK activations. The ERK pathway is
involved in the progression and inhibition of the G1-
to-S phase progression by the differential activations of
Raf-1 3 MEK 3 ERK cascade kinases, which is fol-
lowed by the differential induction of cell cycle regula-
tors such as cyclin D1 and p21Cip/WAF1 (35, 40).
In this study, we monitored the inductions of cyclin
D1 and p21Cip/WAF1 at 10 min and 9 h after treating
HT-29 cells with 10 and 100 M ZnCl2 in MSSM, which
induced transient and prolonged ERK activations, re-
spectively (28). Cyclin D1 was induced 9 h after treat-
ment with 10 or 100 M ZnCl2, and this was higher in
cells treated with the higher concentration of ZnCl2
(Fig. 3). On the other hand, the p21Cip/WAF1 was signif-
icantly induced only in cells treated with 100 M ZnCl2
(Fig. 3). The cyclin D1 and p21Cip/WAF1 inductions by
100 M ZnCl2 were reduced by subsequently treating
cells with PD-98059 (Fig. 4), which suggests that both
cyclin D1 and p21Cip/WAF1 inductions are dependent on
ERK activations.
The effects of zinc on ERK activation, as well as cyclin
D1 and p21Cip/WAF1 induction, resulted in different
Fig. 1. Effects of different concentrations of extracellular zinc on
HT-29 cell growth. Positive and negative regulation of cell growth
and proliferation were affected by extracellular zinc treatment. The
HT-29 colorectal cells were minimal serum starved (the cells were
grown in McCoy’s 5A media containing 1% FBS, called MSSM) for
16 h, and the medium was replaced with MSSM (A) or 10% FBS
medium (B) with different concentrations of ZnCl2 (0, 5, 10, 20, 40,
60, 80, and 100 M). The numbers of attached cells were counted at
0, 48, and 72 h after zinc treatments. C: HT-29 cells were cultured as
shown in A in MSSM, and [3H]thymidine levels were measured 48 h
after replacing medium with media containing different concentra-
tions of zinc as described in METHODS. Values are means SD. Means
with different lowercase letters are significantly different at P 
0.05.
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sensitivities to the zinc concentrations in an extracellu-
lar serum concentration-dependent manner. In contrast
to the cells grown in MSSM, we did not observe inhi-
bition of cell growth by 100 M ZnCl2 in 10% FBS
medium (Fig. 1B). To further characterize the role of
ERK activation in zinc-induced growth regulation, we
measured the effects of 100 M ZnCl2 on ERK activa-
tion and the subsequent cyclin D1 and p21Cip/WAF1
inductions in media containing 10% FBS. We did not
observe prolonged ERK activation by 100 M ZnCl2 in
this medium; only transient ERK activation was ob-
served 10 min after the zinc treatment (Fig. 5). Fur-
thermore, we observed the weak induction of cyclin D1
9 h after treatment with 100 M ZnCl2 in medium
containing 10% FBS, without significant p21Cip/WAF1
induction. These observations of the effects of zinc,
including prolonged ERK activation and p21Cip/WAF1
induction in MSSM, may have been caused by an
inhibitory factor(s) present in the serum or because the
effect of zinc may have been attenuated by signaling
homeostasis of the cells grown in 10% FBS medium.
Both the transient and prolonged ERK activations,
detected within 10 min and 9 h of zinc treatment,
respectively, were redetected in cells grown in 10%
FBS medium containing 500 M ZnCl2 (Fig. 5). In
addition, cyclin D1 and p21Cip/WAF1 inductions were
also observed in cells grown in 10% FBS medium con-
Fig. 2. Effects of PD-98059 on the zinc-induced pos-
itive and negative regulations of cell growth and
proliferation. Essentially, these experiments are the
same as those in Fig. 1A. In the required cases, cells
were incubated with different PD-98059 (PD) con-
centrations (0, 1, 5, or 10 M) for 30 min before
treatment with 10 M ZnCl2 (A) or 100 M ZnCl2
(B). C: [3H]thymidine was measured 48 h after
treatment with zinc. In the required cases, the cells
were incubated with 1 or 10 M PD-98059 for 30
min before zinc treatment. Values are means  SD.
Means with different lowercase letters are signifi-
cantly different at P  0.05.
Fig. 3. ERK activations and inductions of cyclin D1 and p21Cip/WAF1
by 10 and 100 M ZnCl2. A: serum-starved HT-29 cells grown in
MSSM were treated with 10 or 100 M ZnCl2. The cells were then
harvested at different time points (0 min, 10 min, and 9 h), and
Western blot analysis was performed using phospho-ERK (p-ERK),
ERK, cyclin D1, or p21Cip/WAF1 (p21) antibodies. B: same experiment
as in A except that samples were harvested over a greater period of
time to detect cyclin D1 or p21Cip/WAF1.
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taining 500 M ZnCl2. The patterns of ERK activations
and subsequent cyclin D1 and p21Cip/WAF1 inductions
by 100 and 500 M ZnCl2 in 10% FBS medium were
similar to the patterns observed in cells grown in
MSSM containing 10 and 100 M ZnCl2, respectively
(Fig. 3A).
Differential growth regulations by zinc in 10% FBS
medium were associated with prolonged ERK activa-
tion and subsequent p21Cip/WAF1 induction. To measure
the differential effects of zinc in more detail, HT-29
cells were treated with a range of ZnCl2 concentrations
(0, 100, 200, 300, and 500 M) in 10% FBS medium,
and the effects of different zinc concentrations on cell
growth were measured. As observed in MSSM, the
positive and negative regulations of cell growth were
also observed by the higher zinc concentrations in the
10% FBS medium. The number of HT-29 cells was
increased by 100 M ZnCl2 (Fig. 6A). However, the cell
numbers were unaffected by 200 and 300 M ZnCl2
and were reduced as a result of the 300 and 500 M
ZnCl2 treatments (Fig. 6A). p21Cip/WAF1 protein levels
were found to be increased in 10% FBS medium by only
200–500 ZnCl2, and this occurred concomitantly with
prolonged ERK activation (Fig. 6B). On the other hand,
cyclin D1 protein induction was weak at 100 M ZnCl2
and at higher zinc concentrations (200–500 M ZnCl2)
in 10% FBS medium. Both cyclin D1 and p21Cip/WAF1
inductions by zinc in 10% FBS medium were inhibited
by pretreatment with 10 M PD-98059 (Fig. 6B).
Extracellular zinc was not significantly taken up into
HT-29 cells. To identify uptake level of extracellular
zinc in HT-29 colorectal cancer cells, we measured the
Fig. 6. Positive and negative regulations of cell growth and the
differential activation of ERK and induction of p21Cip/WAF1 in 10%
FBS medium by ZnCl2 at concentrations  100 M ZnCl2. A: exper-
iments are as in Fig. 1B except that higher ZnCl2 concentrations (0,
100, 200, 300, and 500 M) were used. Values are means  SD of 3
independent experiments. Means with different lowercase letters are
significantly different at P 0.05. B: experiments are essentially the
same as in Fig. 5, except that a broader range of ZnCl2 concentra-
tions (0, 100, 200, 300, or 500 M) was used. When required, 10 M
PD-98059 was added 1 h before zinc treatment. Cells were harvested
at 9 h after treatment with zinc for Western blot analysis.
Fig. 4. Effects of PD-98059 on cyclin D1 and p21Cip/WAF1 induction.
Serum-starved HT-29 cells grown in MSSM were treated with 100
M ZnCl2. Cells were incubated with 1 or 10 M PD-98059 for 1 h
before zinc treatment. Cells were then harvested, and Western blot
analysis was performed as described in Fig. 3A.
Fig. 5. Prolonged ERK activations and cyclin D1 and p21Cip/WAF1
induction were not observed in 10% FBS medium but were observed
again at a higher extracellular zinc level. Experiments shown are
essentially the same as in Fig. 3A except for the higher ZnCl2
concentrations (100 or 500 M) and that 10% FBS medium was used.
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intracellular zinc levels after adding 10 or 100 M
ZnCl2 to cells grown in MSSM and after adding 500 M
ZnCl2 to cells grown in 10% FBS medium. Intracellular
zinc levels were not found to be significantly increased
by treating cells grown in MSSM with 10 and 100 M
ZnCl2 or in cells grown in 10% FBS containing 500 M
ZnCl2 (Fig. 7). However, the intracellular zinc levels
started to increase soon after adding the Zn2 iono-
phore pyrithione to cells previously treated with 100 or
500 M ZnCl2. Therefore, the high levels of zinc ap-
plied to the culture medium were not significantly
taken up by HT-29 colorectal cancer cells regardless of
the serum levels, and ERK activation may have been
effected via an extracellular zinc sensor such as ZnR
(15) rather than via the activation of intracellular
zinc-sensing protein(s).
DISCUSSION
Zinc is a trace element in the human body and is
known to participate like a growth factor in cellular
proliferation (13, 27, 30). However, zinc has also been
reported to have a growth-inhibitory role (3, 9, 19). The
physiological roles and the mechanisms of zinc partic-
ipation in the regulation of cell growth are not yet fully
understood. The intestinal mucosa undergoes continu-
ous renewal and needs zinc constantly (39). In addi-
tion, zinc was suggested to be a primary determinant of
risk in human colorectal cancer (5, 24, 25, 37), and low
zinc intake may increase the incidence of colorectal
cancer (22). Therefore, it is possible that zinc levels in
the extracellular plasma environment may affect the
growth of colorectal tumors (1, 18).
We recently identified growth arrest in colorectal
cancer cells grown in MSSM containing 100 M ZnCl2
and found that this may have been mediated by the
activation of p21Cip/WAF1 via ERK pathway activation
(28). In the current study, we also observed the growth
stimulation of HT-29 colorectal cancer cells in MSSM
containing 10 M ZnCl2 and in MSSM with 10% FBS
containing 100 M ZnCl2. Therefore, extracellular zinc
is involved in both the positive and negative regulation
of colorectal cancer cell growth, and the direction of
this regulation is dependent on the levels of extracel-
lular zinc. The pH was slightly changed during the
culture period and was not significantly affected by
zinc or FBS concentrations. Therefore, the differential
cell growth induced by zinc may not have been caused
by nonspecific effects such as pH change.
To identify an intracellular signaling mechanism for
the differential regulation of cell growth by extracellu-
lar zinc, we used HT-29 colorectal cancer cells, which
retain putative ZnR (15). These observations of the
positive and negative regulations of HT-29 cell growth
and proliferation by 10 and 100 M ZnCl2 in MSSM
are surprising and suggest that the extracellular zinc-
mediated signal transduction in colorectal cancer cells
is highly dependent on the extracellular zinc level.
Moreover, in MSSM, this cell growth switching point
lies in the range of 10–20 M ZnCl2. The positive and
negative regulations of HT-29 cell growth by 10 and
100 M ZnCl2 were further modulated by subsequent
treatment with PD-98059, suggesting the involvement
of the ERK pathway. The growth inhibition of HT-29
cells by 100 M ZnCl2 in MSSM was abrogated by 1
M PD-98059, which suggests that at 100 M ZnCl2 is
not toxic to HT-29 cells. Moreover, the ERK pathway is
known to be involved in both cellular proliferation and
growth arrest (35, 40). In those studies, only cyclin D1
was weakly induced by the moderate activation of the
ERK pathway, and this induced G1-to-S phase cell
cycle progression. However, both cyclin D1 and p21Cip/
WAF1 were substantially induced by strong ERK path-
way activation, and this blocked G1-to-S phase progres-
sion (40).
The patterns of cyclin D1 and p21Cip/WAF1 inductions
by 10 and 100 M ZnCl2 in MSSM were similar to
those reported in a study of the transient and sus-
tained activation of the ERK pathway (40). The inhi-
bition of cyclin D1 and p21Cip/WAF1 induction by PD-
98059 suggest that these inductions occur via ERK
activation. Furthermore, the regulation of cell growth
and proliferation by different zinc treatments was
highly correlated with the G1-to-S phase progression
observed for different levels of ERK pathway activation
(16, 40). Therefore, we suggest that the ERK pathway
is involved in the positive and negative regulation of
cell growth and proliferation by extracellular zinc and
that this regulation is achieved via the differential
inductions of cell cycle regulators, such as cyclin D1
and p21Cip/WAF1. It is not known why cyclin D1 was
induced with p21Cip/WAF1 in growth- and proliferation-
inhibited cells. The effects of zinc on ERK activation
and cyclin D1 and p21Cip/WAF1 induction were found to
be highly sensitive to serum levels and were not ob-
served in cells grown in 10% FBS medium containing
10 and 100 M ZnCl2. However, the positive and neg-
ative regulation of cell growth were reobserved in 10%
FBS medium containing 100 and 500 M ZnCl2. These
results suggest that the lack of the differential zinc
Fig. 7. Profile of intracellular zinc accumulations caused by extra-
cellular zinc treatment in HT-29 cells and the effect of 1-hydroxy-
pyridine-2-thione (pyrithione). Cells were grown on coverslips
MSSM or 10% FBS medium and were treated with ZnCl2 at 1, 100,
or 500 M. Intracellular zinc concentration ([Zn2]i) was monitored
vs. time. Changes in [Zn2]i were measured by using a ratiometric
fluorescence-recording technique (33). After 30 min, 10 M pyri-
thione was added and zinc uptake was monitored.
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effects in cells treated with 10 and 100 M ZnCl2 in
10% FBS medium may be due to an intracellular ho-
meostasis, which reduces zinc sensitivity.
Correlation between p21Cip/WAF1 induction and pro-
longed ERK activation and the inhibition of p21Cip/
WAF1 induction by PD-98059 confirmed that p21Cip/
WAF1 induction occurs after prolonged ERK activation.
The serum-modulated effects of zinc on cyclin D1 and
p21Cip/WAF1 induction were found to correlate well with
cellular growth. For example, cellular growth was not
inhibited but slightly enhanced by 100 M ZnCl2 in
10% FBS medium, and under this condition cyclin D1
was induced and p21Cip/WAF1 was not. On the other
hand, the level of cell growth was reduced by treatment
with 300–500 M ZnCl2, where the p21Cip/WAF1 levels
were most increased.
The zinc concentrations (100–500 M of ZnCl2) used
in the present study to activate ERKs and differential
cell growth in media containing 10% FBS were higher
than the zinc levels in plasma and in the luminal
surface of enterocytes, where relatively high zinc con-
centration was observed (11). However, we found that
intracellular zinc levels were not increased by treat-
ment with 100–500 M ZnCl2. These results suggest
that the zinc-mediated differential growth regulation
of HT-29 colorectal cancer cells may be achieved via
extracellular receptor-mediated ERK pathway activa-
tion and the subsequent induction of cell cycle regula-
tors such as p21Cip/WAF1.
Our identification of positive and negative growth
regulation of colorectal cancer cells by extracellular
zinc and other epidemiological studies related to zinc
(9, 10, 26, 37) suggest that an adequate intake and the
right dosage of zinc is important to maintain good
health and prevent disease.
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